Media Summary: Dr Martin Voss, (Memorial Sloan Kettering Cancer Centre, New York City, USA) talks to ecancertv at ASCO GU 2015 on part 1 of ... This video is a part of a larger educational program entitled: Patient Care in Kidney Cancer: What You Need to Know Along Your ... Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...
Dalantercept Plus Axitinib Versus Placebo - Detailed Analysis & Overview
Dr Martin Voss, (Memorial Sloan Kettering Cancer Centre, New York City, USA) talks to ecancertv at ASCO GU 2015 on part 1 of ... This video is a part of a larger educational program entitled: Patient Care in Kidney Cancer: What You Need to Know Along Your ... Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ... To cite: Keystone EC, Taylor PC, Tanaka Y, et al. Annals of the Rheumatic Diseases 2017;76:1853-1861. Read the full article ... Brian Rini, MD, from the Cleveland Clinic Taussig Cancer Institute on the results from his [Key Takeaway] Benralizumab showed a significant reduction in the risk of HES flares. Journal: Nat Med Published: March ...
David Quinn, MBBS, PhD, FRACP, from the USC Norris Comprehensive Cancer Center, Los Angeles, CA, presents the latest ... Lead investigator Brian I. Rini, MD, a staff member in the Department of Solid Tumor Oncology at the Taussig Cancer Institute at ... Nazli Dizman, MD, an Internal Medicine Resident at Yale University, spoke with us about the combination of pembrolizumab and ... [Key Takeaway] Venglustat did not change TKV and had worsened eGFR in rapidly progressing ADPKD. Journal: American ...
